One step at a time, those who are diagnosed with rare neuropathic conditions such as GBS or CIDP prove it's possible to get ...

Studies have found important benefits from the new RSV immunization and enhanced versions of the flu shot. Plus, the shingles ...

In the past decade, the world confronted several pandemics of emerging infectious diseases including Zika virus and most recently Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). One of ...

For older adults who express more confidence in vaccine safety than younger groups, the past few months have brought welcome ...

The precipitating cause of Guillain-Barré syndrome is not always obvious. In most cases, a flu-like illness induced by a variety of pathogenic agents precedes the neurologic symptoms by ~10 days.

A 1 1/2-year-old previously healthy child was hospitalized for progressive weakness for 5 days. Ten days before admission, he received the first dose of the hepatitis A vaccine (HAVRIX 720). Five ...

Flickr, the world's biggest and friendliest online photography community, now supports version 4.0 of the Creative Commons license suite, marking a significant milestone in the evolution of open ...

Flickr, the world's biggest and friendliest online photography community, now supports version 4.0 of the Creative Commons license suite, marking a significant milestone in the evolution of open ...

Citation Doets AY, Hughes RAC, Brassington R, Hadden RDM, Pritchard J. Pharmacological treatment other than corticosteroids, intravenous immunoglobulin and plasma exchange for Guillain-Barré syndrome.

The Creative Commons licenses are a collection of public copyright licenses released by the non-profit, Creative Commons. There are various types of Creative Commons licenses available with varying ...

To know the impact of the Guillain Barré syndrome (GBS) in the population less than 15 years old, after the eradication of poliomyelitis. Data bank from the program of epidemiological surveillance of ...

--Hansa Biopharma AB, "Hansa" today announced that it will host a virtual investor event on Guillain-Barré syndrome on Monday, June 16, 2025 at 14:00 CEST/ 8:00 AM EDT. David R. Cornblath, MD ...